AMG-548

SynDRA canonical compound SYN0020263 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	MAPK11 \| MAPK12 \| MAPK13 \| MAPK14 \| TNF
Mechanism of action	MAP kinase inhibitor

All known targets

MAPK14
MAPK11
MAPK12
MAPK13
TNF

Mechanisms of action (all sources)

MAPK14 INHIBITOR
MAP kinase p38 alpha inhibitor
MEK inhibitor

Cross-references

PubChem CID: 11167112
ChEMBL: CHEMBL585902
TTD: D02MVG

Synonyms

P38 MAP kinase inhibitor, Amgen
UNII-PGR0H531I4
PGR0H531I4
RefChem:111928
SCHEMBL433425
orb1710450
SCHEMBL29395852
C29H27N5O
GLXC-03325
PJB24960
BDBM50303597
EX-A14494
MFCD26792556
AKOS024457873
AT33611
T10298L
NCGC00370979-01
NCGC00370979-02
AS-88284
DA-60979
HY-108642
CS-0029376
BRD-K86673452-001-01-7
BRD-K86673452-001-02-5

Look up AMG-548 in the interactive SynDRA portal →